Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma：a Randomized Controlled Study
Who is this study for? Patients with superficial Kaposiform hemangioendothelioma and tufted angioma
What treatments are being studied? Tacrolimus
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
The aim of this study was to evaluate the efficacy and safety of topical application of tacrolimus at different concentrations for superficial Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA).
Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:
• Children with superficial Kaposiform hemangioendothelioma (KHE) and tufted angioma (TA)
Locations
Other Locations
China
West China Hospital of Sichuan University
RECRUITING
Chengdu
Contact Information
Primary
Yi Ji, PHD, MD
jijiyuanyuan@163.com
+86 13980544622
Time Frame
Start Date: 2019-09-01
Estimated Completion Date: 2024-10-28
Participants
Target number of participants: 50
Treatments
Experimental: patients treated with tacrolimus 0.03% ointment
patients treated with tacrolimus 0.03% ointment
Active_comparator: patients treated with tacrolimus 0.1% ointment
patients treated with tacrolimus 0.1% ointment
Related Therapeutic Areas
Sponsors
Leads: West China Hospital